SCHEMBL7984647

SCHEMBL7984647

Nc1ccc2c(c1N)CN(Cc1ccc(C(F)(F)F)cc1)CC2

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
PNMT P11086 1/20 0.44
ACACB O00763 1/20 0.43
CLPP Q16740 5/20 0.43
CHKA P35790 1/20 0.42
GPR132 Q9UNW8 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
OPRL1 P41146 2/20 0.41
HIF1A Q16665 1/20 0.40
EPAS1 Q99814 1/20 0.40
COMT P21964 1/20 0.40
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
TACR1 P25103 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7981194 0.89 KDM4E (0.47) KDM4EALDH1A1ACACBCLPPCHKA
SCHEMBL8188636 0.79 KDM4E (0.45) KDM4EALDH1A1ACACBCLPPCHKA
SCHEMBL4157838 0.75 MEN1 (0.58) KDM4EALDH1A1POLB
Bromide SCHEMBL7984185 0.75 ALDH1A1 (0.51) KDM4EALDH1A1ACACBDRD2DRD3
SCHEMBL7984349 0.74 CLPP (0.48) KDM4EALDH1A1ACACBCLPPDRD2
SCHEMBL7100836 0.73 PNMT (0.58) PNMTDRD2
SCHEMBL17565147 0.73 ACACB (0.57) KDM4EALDH1A1ACACBCLPPCHKA
SCHEMBL2095548 0.73 ACACB (0.57) KDM4EALDH1A1ACACBCLPPCHKA
SCHEMBL21237593 0.72 KDM4E (0.46) KDM4EALDH1A1PNMTACACBCLPP
Bromide SCHEMBL6790707 0.72 PNMT (0.56) PNMTDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6197771-B1 NERVOUS SYSTEM DISORDERS; ANTIISCHEMIC AGENTS; ALZHEIMER'SDISEASE; PARKINSON'S DISEASE; HUNTINGTON'S DISEASE WARNER-LAMBERT COMPANY 2001-03-06 US claimed
WO-1996028445-A1 NOVEL GLUTAMATE (AMPA/KAINATE) RECEPTOR ANTAGONISTS: N-SUBSTITUTED FUSED AZACYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-09-19 WO claimed
US-6197771-B1 NERVOUS SYSTEM DISORDERS; ANTIISCHEMIC AGENTS; ALZHEIMER'SDISEASE; PARKINSON'S DISEASE; HUNTINGTON'S DISEASE WARNER-LAMBERT COMPANY 2001-03-06 US disclosed
US-6057313-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 2000-05-02 US disclosed
WO-1996028445-A1 NOVEL GLUTAMATE (AMPA/KAINATE) RECEPTOR ANTAGONISTS: N-SUBSTITUTED FUSED AZACYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-09-19 WO disclosed